Use of natural cysteine protease inhibitors in limiting SARS-Co-2 fusion into human respiratory cells

Specific antibodies that humans acquire as a result of disease or after vaccination are needed to effectively suppress infection with a specific variant of SARS CoV-2 virus. The S protein of the D614G variant of coronavirus is used as an antigen in known vaccines to date. It is known that COVID-19 d...

Descripción completa

Detalles Bibliográficos
Autores principales: Siewiński, Maciej, Bażanów, Barbara, Orzechowska, Beata, Gołąb, Krzysztof, Gburek, Jakub, Matkowski, Adam, Rapak, Andrzej, Janocha, Anna, Krata, Lechosław, Dobrzyński, Maciej, Kilar, Ewa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598048/
https://www.ncbi.nlm.nih.gov/pubmed/36313266
http://dx.doi.org/10.1016/j.mehy.2022.110965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598048/
https://www.ncbi.nlm.nih.gov/pubmed/36313266
http://dx.doi.org/10.1016/j.mehy.2022.110965

Ejemplares similares